Keywords: business, spending, australia, soars, record, billion, boosted
Business spending on R&D in Australia soars to record A$10.1 billion, boosted by pharma
Article | 10 September 2007
Australia's business expenditure on R&D (BERD) rose to a record A$10.1 billion ($8.37 billon) in 2005-6. New data from the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
